PatnaDr Abhishek Anand is a Medical Oncologist with excellent training from the prestigious Kidwai Cancer Institute, Bangalore. He has 8 years of extensive experience in treating all types of solid cancers, lymphoma and leukemias. He is also keenly involved in targeted therapies and precision medicine. He is well trained in performing stem cell transplant. He has also been associated with AIIMS, New Delhi, where he got experience in managing medical emergencies. He got his post graduate training in Internal Medicine from the reputed PMCH, Patna. He has got many research work and publications to his credit.
Book An Appointment
Fees Details
| Doctor Fee | |
| Total |
Emergency
0124-4585666 (Gurugram)
09103327357 (Srinagar)
0172-5294455 (Panchkula)
0612-7107788 (Patna)
0294-6669911 (Udaipur)
07070405405 (Darbhanga)
0651-7107600 (Ranchi)
Didn’t Find What You Were Looking For
Get a call back from our Health Advisor
Dr. Abhishek Anand
HOD & SR. Consultant
Paras Hospitals, Patna
Medical Oncology
Registration Number : (BCMR-37966)
Education: MBBS, MD(Medicine), DM - Medical Oncology
Language Spoken: Hindi, English
About Dr. Abhishek Anand
About Dr. Abhishek Anand
Previous Experience:
Previous Experience
Senior Resident – In Emergency Medicine from AIIMS, New Delhi .
Specialty Interest:
Specialty Interest
Breast Cancer
Sarcoma and Genitourinary
Lung Cancer
GI Cancer
Lymphoma & Leukemia
Other Solid Malignancies
Education and Fellowships:
Education and Fellowships
DM- Medical Oncology, Kidwai Cancer Institute Bangalore
MD- Medicine –PMCH, Patna
MBBS- NMCH-Patna
Professional Memberships:
Professional Memberships
ESMO
ASCO
ISMPO
Awards and Honors:
Awards and Honors
University topper and Gold medalist in MBBS
Won 1st prize in quiz competition at 38th ICON national conference, Kochi, March 2018
Research and Publications:
Research and Publications
Clinicopathological Profile and Treatment Outcomes of Bilateral Breast Cancer: A Study from Tertiary Cancer Center in South India.
Role of Taxanes in Triple-Negative Breast Cancer: A Study From Tertiary Cancer Center in South India“
Primary Breast Angiosarcoma – A single Institution experience from a Tertiary Cancer Center in South India.
Clinical Profile and Treatment outcomes of Advanced Metastatic Neuro-endocrine Carcinoma: A Single Institution Experience.
Correlation of BMI with breast cancer subtype and tumor size.
T-cell Prolymphocytic Leukemia : An experience from a Tertiary Cancer Centre in South India
Genomic Profling of non-small cell Lung Cancer: A pilot study from South India
Dual Mutations and Complex Mutations in Metastatic nonsmall cell Lung Cancer: A Single Institution Experience from South India
Clinico-pathological profile and treatment outcome of Squamous Cell Carcinoma Breast at a Tertiary Cancer Center in South India.
Rare Occurance: Cutaneous Metastasis to scalp and upper lip from Gastroesophageal Carcinoma.
Acute Lymphoblastic Leukemia with Neuro-fibromatosis 1: A case report
Effects of Vildagliptin on glucose control in patients with type 2 Diabetes inadequately controlled with Metformin.
Cytological Diagnosis of Rosai Dorfman disease in region of neck.
Histo-pathological Study of Endometrium in Dysfunctional Uterine Bleeding.
Case report- Study on ultrasound guided Fine Needle Aspiration Cytology of Liver Lesions.
Presentations at National and International Conferences:
Asia Pacific Breast Cancer Summit Feb 2017, Hong Kong: A study of Bilateral Breast Cancer from a Tertiary Cancer Center.
UAE Cancer Congress Oct 2017, Dubai: Clinical relevance of Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer.
Systems Oncology March 2017, Kochi: CtDNA based molecular profiling of NSCLC.
Indian Cancer Congress Nov 2017, Bangalore: Discordance of ER, PR, HER2 in Recurrent Breast Cancer.
Indian Cancer Congress Nov 2017, Bangalore: Squamous Cell Carcinoma Breast: clinical profile and survival outcomes from a single institution.
38th ICON, March 2018, Kochi: Association of TILs in Triple Negative Breast Cancer Survival.
38th ICON, March 2018, Kochi: Clinical study of Recurrent Breast Cancer from a Tertiary Cancer Center (Thesis Competition).
AROICON, Nov 2010, Patna: Role of Taxane in treatment of NHL.
AROICON, Nov 2010Patna: Role of Temozolamide in Glioblastoma Multiforme
BOOK AN APPOINTMENT
Fees Details
| Doctor Fee | |
| Total | 0 |
About Paras Health
Since 2006, Paras Health has aimed to build a healthy Bharat by providing affordable, accessible, and high-quality healthcare services. Paras Health’s mission is to make affordable and quality tertiary health accessible to communities that lack such services. Paras Health’s visual identity emphasizes its 4 brand values - Compassion, Accessibility, Affordability and Quality that converge to make its vision a reality for all Bhartiyas. Paras Health has been delivering world-class clinical outcomes by staying abreast with the latest developments in the scientific field and combining cutting-edge technology with our extensive & renowned medical expertise.
The company is a network of 6 hospitals in Northern India that operates 1500 beds as of date. The chain started with its first hospital in Gurugram in 2006, expanded to Patna, Darbhanga, Udaipur, Panchkula, Ranchi, and now extending itself to Srinagar & Kanpur. Paras Health aspires to be the largest private healthcare provider in North India by 2031 with 9000+ beds under its network. Of this, around 5000 beds will be added by FY 2028 through organic and inorganic expansion. The committed expansion pipeline of 2,000 + beds will be met through expansion at Kanpur, Srinagar, and Panchkula.
Since 2006, Paras Health has aimed to build a healthy Bharat by providing affordable, accessible, and high-quality healthcare services. Paras Health’s mission is to make affordable and quality tertiary health accessible to communities that lack such services. Paras Health’s visual identity emphasizes its 4 brand values - Compassion, ..